CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer

Piero Dalerba, Debashis Sahoo, Soonmyung Paik, Xiangqian Guo, Greg Yothers, Nan Song, Nate Wilcox-Fogel, Erna Forgó, Pradeep S. Rajendran, Stephen P. Miranda, Shigeo Hisamori, Jacqueline Hutchison, Tomer Kalisky, Dalong Qian, Norman Wolmark, George A. Fisher, Matt Van De Rijn, Michael F. Clarke

Research output: Contribution to journalReview articlepeer-review

354 Scopus citations

Fingerprint

Dive into the research topics of 'CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry